GlassScriptPhysician profile
Maria J Apigo
NPI 1306836408
$2,890.30
in general payments reported to CMS, 2019-2025
42 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $420 · 2021: $751 · 2022: $581 · 2023: $366 · 2024: $182 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $486.30 | 2020-2022 | |
| Daiichi Sankyo INC. | $396.80 | 2019-2024 | Injectafer |
| Organon LLC | $156.83 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $137.71 | 2021-2023 | |
| Therapeuticsmd, INC. | $132.43 | 2020-2022 | |
| Coopersurgical, INC. | $123.92 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $115.99 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $108.71 | 2019-2025 | |
| Aspira Women'S Health INC | $99.35 | 2019-2024 | Ova1 |
| Hologic Sales and Service, LLC | $94.62 | 2023-2025 | Aptima, Acessa Provu System |
| Astellas Pharma US INC | $71.63 | 2024-2025 | Veozah |
| Millicent US INC | $70.92 | 2020 | |
| Avion Pharmaceuticals | $61.13 | 2019-2023 | Balcoltra |
| Biogen, INC. | $57.03 | 2025 | Zurzuvae |
| Lupin INC. | $56.13 | 2019-2020 |
Show all 41 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Apigo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.